Refractory Angina Pectoris clinical trials

Explore recruiting refractory angina pectoris clinical trials.

Recruiting refractory angina pectoris studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Angina Pectoris trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety (EXACT-2 Trial)

Belgium, Poland, Hungary, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Refractory Angina Pectoris trials by city

Refractory Angina Pectoris clinical trials

Recruiting refractory angina pectoris studies right now

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

Also recruiting in Europe

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety (EXACT-2 Trial)

Refractory Angina Pectoris trials by city

Other conditions